Health checklist for women over 40: screenings, hormones, and prevention
The essential health screening checklist for women over 40. Learn which blood tests, cancer screenings, hormonal assessments, and bone health checks to get — and how often.
After 40, a woman’s body enters its most dynamic decade of change. Estrogen begins its gradual decline toward menopause. Bone density loss accelerates — sometimes dramatically. Cardiovascular risk, long suppressed by hormonal protection, starts catching up with men. And certain cancers enter their peak detection window.
Yet most women over 40 are under-screened. Standard annual physicals miss critical markers. Hormonal changes are dismissed as “normal aging.” And the gap between what medicine considers “normal” and what actually promotes longevity is often enormous.
This is the evidence-based health screening checklist every woman over 40 needs — covering blood work, cancer screenings, hormonal assessments, and functional tests that predict how well you’ll age.
What you’ll learn:
- The 10 essential health tests after 40
- Hormonal health: what to test and when
- Cancer screenings: the critical timeline
- Functional fitness tests for women
- Complete screening schedule
- How SuperAge helps you track your health
- FAQ
The 10 essential health tests for women over 40
1. Comprehensive lipid panel with ApoB
What it measures: Total cholesterol, LDL-C, HDL-C, triglycerides, ApoB, and ideally Lp(a).
Why it matters after 40: Heart disease is the #1 killer of women — not breast cancer. Before menopause, estrogen provides significant cardiovascular protection. As estrogen declines in the 40s and 50s, LDL cholesterol rises by an average of 10-15%, and cardiovascular risk climbs sharply. Many women are shocked to see their “perfect” lipid profile deteriorate seemingly overnight during perimenopause.
Optimal ranges:
| Marker | Lab “normal” | Longevity optimal |
|---|---|---|
| LDL-C | < 130 mg/dL (3.4 mmol/L) | < 100 mg/dL (2.6 mmol/L) |
| HDL-C | > 50 mg/dL (1.3 mmol/L) | > 65 mg/dL (1.7 mmol/L) |
| Triglycerides | < 150 mg/dL (1.7 mmol/L) | < 90 mg/dL (1.0 mmol/L) |
| TG/HDL ratio | < 3.5 | < 1.5 |
| ApoB | < 130 mg/dL | < 80 mg/dL |
How often: Every 1-2 years. More frequently during perimenopause when values may change rapidly.
2. Metabolic panel: fasting glucose, HbA1c, and fasting insulin
What it measures: Blood sugar regulation and insulin sensitivity.
Why it matters after 40: Insulin resistance is a silent epidemic in perimenopausal women. Declining estrogen impairs glucose metabolism, and many women develop prediabetes in their late 40s without knowing it. Fasting insulin is the earliest warning signal — it rises years before glucose or HbA1c become abnormal.
If these markers are drifting during cycle changes, read insulin resistance in perimenopause for the hormone, sleep, waist, and muscle mechanisms behind the pattern.
If waist or scale weight is the first concern, weight gain in perimenopause vs aging separates age-driven gain from perimenopause redistribution.
Optimal ranges:
| Marker | Diagnostic threshold | Longevity optimal |
|---|---|---|
| Fasting glucose | < 100 mg/dL (5.6 mmol/L) | 72-85 mg/dL (4.0-4.7 mmol/L) |
| HbA1c | < 5.7% | < 5.3% |
| Fasting insulin | < 25 μIU/mL | < 6 μIU/mL |
How often: Annually.
3. Thyroid panel (TSH, free T4, TPO antibodies)
What it measures: Thyroid hormone production, regulation, and autoimmune thyroid disease.
Why it matters after 40: Women are 5-8x more likely than men to develop thyroid disorders. Hashimoto’s thyroiditis (autoimmune hypothyroidism) peaks in the 40s and 50s, and its symptoms — fatigue, weight gain, hair loss, brain fog, depression — are frequently misattributed to perimenopause. Thyroid dysfunction accelerates biological aging and worsens menopausal symptoms.
What to test:
| Marker | Optimal range |
|---|---|
| TSH | 1.0-2.5 mIU/L |
| Free T4 | Mid-range for lab |
| Free T3 | Mid-upper range |
| TPO antibodies | < 35 IU/mL (negative) |
Important: Always test TPO antibodies at least once. Elevated antibodies can predict thyroid failure years before TSH becomes abnormal — giving you time for early intervention.
How often: Every 1-2 years. Annually if TPO antibodies are positive.
4. Complete blood count (CBC) with differential
What it measures: Red blood cells, white blood cells, platelets, and subtypes.
Why it matters after 40: Women over 40 are at higher risk for iron-deficiency anemia (from heavy perimenopausal periods), B12 deficiency, and immune changes. The neutrophil-to-lymphocyte ratio and WBC count track chronic inflammation — a key driver of biological aging.
Key markers:
| Marker | Women-specific note |
|---|---|
| Hemoglobin | < 12 g/dL = anemia; common with heavy periods |
| Ferritin | Optimal 40-100 ng/mL; < 30 = iron depletion even without anemia |
| MCV | Elevated = possible B12 or folate deficiency |
| NLR | Optimal < 2.0; higher values = chronic inflammation |
How often: Annually.
5. Iron studies (ferritin, iron, TIBC)
What it measures: Iron stores and iron metabolism.
Why it matters after 40: Iron has a unique U-shaped risk curve for women. Before menopause, heavy periods can deplete iron stores, causing fatigue, brain fog, and hair loss even without frank anemia. After menopause, iron accumulates — and excess iron is pro-inflammatory and oxidative, accelerating aging. Testing ferritin at regular intervals helps you navigate this transition.
Optimal ferritin: 40-100 ng/mL at any age. Below 30 ng/mL is depleted. Above 150 ng/mL (postmenopausal) warrants investigation.
How often: Annually if still menstruating. Every 2-3 years postmenopause.
6. Inflammatory markers: hs-CRP and homocysteine
What they measure: Systemic inflammation and methylation status.
Why they matter after 40: Chronic inflammation accelerates dramatically during the menopausal transition. Estrogen is anti-inflammatory; as it declines, hs-CRP levels typically rise. Homocysteine is an independent cardiovascular risk factor that tends to increase with age and is modifiable with B vitamins.
Optimal ranges:
| Marker | Longevity optimal |
|---|---|
| hs-CRP | < 1.0 mg/L |
| Homocysteine | < 10 μmol/L |
How often: Annually.
7. Vitamin D + calcium
What they measure: Bone-protective nutrients critical for women.
Why they matter after 40: Women lose up to 20% of their bone density in the 5-7 years after menopause. Adequate vitamin D and calcium are the foundation of bone protection — and most women are deficient in at least one.
Optimal ranges:
- Vitamin D (25-OH): 40-60 ng/mL (100-150 nmol/L)
- Calcium (serum): 8.5-10.2 mg/dL (2.1-2.6 mmol/L)
How often: Vitamin D annually. Calcium as part of metabolic panel.
Hormonal health: what to test and when
8. Reproductive and menopausal hormones
The hormonal landscape shifts dramatically between 40 and 55. Understanding your hormone levels helps distinguish normal perimenopause from thyroid disease, adrenal dysfunction, or other conditions.
The perimenopause panel:
| Hormone | What it tells you | When to test |
|---|---|---|
| FSH | Rising FSH (> 25 mIU/mL) suggests approaching menopause | Day 3 of cycle (or any day if irregular) |
| Estradiol (E2) | Declining E2 correlates with symptoms | Day 3 of cycle |
| DHEA-S | Adrenal reserve; declines with aging | Any day |
| Progesterone | Confirms ovulation; often first hormone to decline | Day 21 of cycle |
| Testosterone | Female androgen context; libido, muscle, SHBG, and therapy limits | Any day |
When to test: If you’re experiencing irregular periods, hot flashes, sleep disruption, mood changes, vaginal dryness, or unexplained fatigue. These symptoms often begin 4-8 years before the final menstrual period.
For a detailed breakdown of how FSH, estradiol, and AMH each perform at different stages of transition — including which test to request first and when each one fails — see FSH vs estradiol vs AMH in perimenopause.
Estrogen and longevity
Estrogen doesn’t just manage symptoms — it’s a longevity hormone. It protects the cardiovascular system, maintains bone density, supports brain health, and modulates inflammation. The decline of estrogen during menopause is associated with accelerated biological aging, which is why menopausal women can see their biological age jump by 2-4 years during the transition.
How often: During perimenopause, every 6-12 months to track the transition. After established menopause, as clinically indicated. Once cycles have stopped for 12 months, shift from transition testing to a postmenopause blood test checklist focused on cardiometabolic, bone, thyroid, kidney, liver, and anemia context.
Cancer screenings: the critical timeline
9. Mammography
Breast cancer risk increases significantly after 40. Current guidelines:
| Organization | Recommended start | Frequency |
|---|---|---|
| American Cancer Society | 40 (optional), 45 (strongly) | Annual 45-54, then every 1-2 years |
| USPSTF (2024 update) | 40 | Every 2 years |
| ACR (American College of Radiology) | 40 | Annual |
Higher risk? If you have a first-degree relative with breast cancer, BRCA1/2 mutation, or prior chest radiation, discuss starting screening earlier and adding breast MRI.
Screening is designed for people without symptoms; new focal breast pain or warning signs need their own clinical evaluation even when routine mammography is current.
10. Cervical cancer screening (Pap + HPV)
| Age | Test | Frequency |
|---|---|---|
| 21-29 | Pap smear alone | Every 3 years |
| 30-65 | Pap + HPV co-testing | Every 5 years |
| 30-65 | HPV primary testing | Every 5 years |
| 65+ | May stop if adequate prior screening | — |
Colorectal cancer screening
Same as men: begin at age 45 (40 if high risk). Colonoscopy every 10 years, or annual FIT/stool-based test. Colorectal cancer rates are rising in younger adults — don’t skip this.
Functional fitness tests for women
Blood work reveals what’s happening internally. Functional tests show how your body performs. Both predict longevity.
The 5 essential self-tests for women
| Test | What it measures | Benchmark (women 40-60) |
|---|---|---|
| Grip strength | Overall strength and mortality risk | > 55 lbs (25 kg) |
| Sit-to-stand test | Lower body power | > 15 reps in 30 seconds |
| Single-leg balance | Balance and fall risk | > 25 seconds eyes closed |
| Walking speed | Overall vitality | > 2.5 mph (4.0 km/h) |
| VO2 max estimate | Cardiovascular fitness | > 30 mL/kg/min |
Why strength matters more for women
Women naturally have less muscle mass than men and lose it faster after menopause (when anabolic hormones decline). Sarcopenia — age-related muscle loss — combined with bone density loss creates a compounding risk of fractures, disability, and loss of independence. Strength training isn’t optional after 40; it’s a medical necessity.
Complete screening schedule
| Test | Frequency | Starting age |
|---|---|---|
| Lipid panel (with ApoB) | Every 1-2 years | 40 |
| Metabolic panel (glucose, HbA1c, insulin) | Annually | 40 |
| Thyroid panel (TSH, fT4, TPO) | Every 1-2 years | 40 |
| CBC with differential | Annually | 40 |
| Iron studies (ferritin) | Annually (premenopausal) | 40 |
| hs-CRP + homocysteine | Annually | 40 |
| Vitamin D | Annually | 40 |
| Hormone panel | Per symptoms/transition | Perimenopause onset |
| Mammography | Per guideline/risk | 40 |
| Pap + HPV | Every 5 years | 30 (continue past 40) |
| Colonoscopy or stool screening | Per protocol | 45 (40 if high risk) |
| DEXA bone density | Every 2 years | 50 (earlier if risk factors) |
| Lp(a) | Once (lifetime) | 40 |
| Coronary calcium score | Per risk assessment | 50+ or earlier if high risk |
Health screenings and biological age
The blood markers on this checklist overlap significantly with the biomarkers used in PhenoAge and KDM biological age algorithms. Every annual blood panel is also, implicitly, a biological age measurement.
For women specifically, biological age tracking is especially powerful during the menopausal transition — it provides an objective measure of whether hormone changes are accelerating aging and whether interventions (lifestyle, HRT, supplementation) are working.
Research shows that women who actively manage the menopausal transition — through strength training, sleep optimization, stress management, and appropriate medical interventions — can partially offset the biological age acceleration that menopause typically triggers.
How SuperAge helps you track your health
SuperAge is designed to make health tracking effortless:
Daily cardiovascular monitoring
Through Apple Watch, SuperAge tracks the metrics that matter most for women’s cardiovascular health:
- Resting heart rate trends
- HRV — especially valuable for tracking stress and hormonal fluctuations
- VO2 max — cardiovascular fitness trajectory
- Walking metrics — speed, step length, balance indicators
Blood test integration
Log your lab results in SuperAge to track trends over time. The app uses longevity-optimal reference ranges — not just standard lab “normal” — to flag markers that deserve attention.
Biological age tracking
SuperAge calculates your biological age from multiple data sources and shows how it changes over time. For women navigating perimenopause and menopause, this provides a clear, objective signal of how your body is responding to the transition — and whether your interventions are working.
Frequently asked questions
I’m still getting periods — do I need perimenopausal testing?
If you’re over 40 and experiencing changes in cycle length, heavier or lighter periods, sleep disruption, hot flashes, mood swings, or new-onset anxiety, you may be in perimenopause — even if you’re still menstruating regularly. Hormone testing can clarify whether your symptoms are perimenopausal, thyroid-related, or something else.
Should I get a DEXA scan before menopause?
If you have risk factors for osteoporosis (low body weight, family history, smoking, prolonged amenorrhea, eating disorder history, corticosteroid use, or autoimmune disease), getting a baseline DEXA before menopause is valuable. Otherwise, most guidelines recommend starting at 50 or at menopause, whichever comes first.
Is hormone replacement therapy (HRT) safe?
Current evidence suggests that HRT initiated within 10 years of menopause onset (or before age 60) has a favorable benefit-risk profile for most women — reducing cardiovascular risk, bone loss, and symptom burden. The outdated fear from the 2002 WHI study has been substantially revised by subsequent analysis. Discuss your individual risk profile with a menopause-informed healthcare provider.
How much will these screenings cost?
Most blood tests are covered by insurance as part of an annual physical. Mammography is covered as preventive care. DEXA scans are typically covered for women 50+ with risk factors. For tests not ordered by your doctor (ApoB, Lp(a), fasting insulin), direct-to-consumer labs offer comprehensive panels for $200-400.
What about the health checklist for men?
If you’re looking for the male-specific version — covering testosterone, PSA, and prostate health — see the health checklist for men over 40.
Key takeaways
- Heart disease, not breast cancer, is the #1 threat to women over 40 — get a comprehensive lipid panel with ApoB
- Thyroid disorders affect 1 in 8 women — always test TPO antibodies at least once
- Perimenopause begins earlier than most expect — hormone testing clarifies symptoms
- Bone density screening before or at menopause establishes a critical baseline
- Fasting insulin is the earliest metabolic warning — catches insulin resistance years before glucose rises
- Strength training is a medical necessity after 40, not just a fitness choice
- Track your biological age through the transition to measure whether your interventions are working
Take control of your health today
Your 40s are not the beginning of decline — they’re the decade where informed action has the greatest impact on your next 40 years.
Ready to start tracking? Download SuperAge and monitor your cardiovascular health, biological age, and fitness metrics every day.
For a narrower decision guide, see Midlife health audit: what to measure before symptoms appear.
References
- Mosca L et al. — “Effectiveness-Based Guidelines for the Prevention of Cardiovascular Disease in Women.” Circulation (2011)
- USPSTF — “Screening for Breast Cancer: Recommendation Statement.” (2024)
- El Khoudary SR et al. — “Menopause Transition and Cardiovascular Disease Risk.” JACC (2020)
- Levine ME et al. — “Menopause accelerates biological aging.” PNAS (2016)
- Writing Group for the WHI Investigators — “Risks and Benefits of Estrogen Plus Progestin: Principal Results.” JAMA (2002); subsequent reanalysis (2013, 2017)
- Cruz-Jentoft AJ et al. — “Sarcopenia: revised European consensus.” Age and Ageing (2019)
Last updated: 2026-03-28. This article is regularly reviewed to ensure accuracy.
Related Articles
Health checklist for men over 40: the 10 tests that matter most
The essential health screening checklist for men over 40. Learn which blood tests, physical exams, and fitness assessments to get — and how often — to catch problems early.
